Abiopharma

News list

Venkatachaliah Girish 🟡 adjusted position in 27.5K shares of agilon health, inc. (AGL) at $9.75 Transaction Date: Apr 01, 2026 | Filing ID: 023764

Full text

News bot April 3, 2026, 11:38 p.m.
🔍 Venkatachaliah Girish (Executive)

Company: agilon health, inc. (AGL)

Report Date: 2026-04-01
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 0
- Holdings reported: 0
- Total shares acquired: 28,000
- Total shares sold: 480
Detailed Transactions and Holdings:
- Sold 480 shares of Common Stock at $9.75 per share (Direct)
  Date: 2026-04-01 | Code: F | equity_swap_involved: 0 | shares_owned_after: 10,662.00 | transaction_form_type: 4 | Footnotes: F1, F2
- Acquired 28,000 shares of Common Stock (Direct)
  Date: 2026-04-01 | Code: A | equity_swap_involved: 0 | shares_owned_after: 38,662.00 | transaction_form_type: 4 | Footnotes: F3, F4
Footnotes:
- F1: Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of the restricted stock units and does not represent a sale.
- F2: The amount of securities beneficially owned following the reported transaction reflects the 1 for 25 reverse stock split of the Issuer's issued and outstanding common stock effective March 30, 2026.
- F3: Restricted stock units that vest in three equal installments on each anniversary of April 1, 2026, subject to continued employment.
- F4: Includes restricted stock units.